Correlation between intestinal microbes and the efficacy of bevacizumab / PD-1 monoclonal antibody therapy in patients with colorectal cancer

ABSTRACT: Interventions: Case series:bevacizumab / PD-1 monoclonal antibody treatment Primary outcome(s): 16S sequencing Study Design: Single arm

DISEASE(S): Colorectal Cancer

PROVIDER: 2689011 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR